Erin VanDyke Congratulates IU Health on Joining the NBCA COE Program
Erin VanDyke, PA-C, MPAS, Vice President of National Blood Clot Alliance Centers of Excellence, reposted from NBCA on LinkedIn:
”Congrats to the VTE teams at IU Health and welcome to the National Blood Clot Alliance COE program!!
We are so excited for this partnership and for the VTE excellence this team brings to Indiana.
Great things happen when patients, clinicians, and community come together!
Looking forward to the path forward..together!!
NBCA posted on LinkedIn:
”Great news for blood clot patients in Indiana!
The National Blood Clot Alliance (NBCA) is proud to announce IU Health Methodist Hospital in Indianapolis as the state’s first NBCA Venous Thromboembolism (VTE) Center of Excellence™, joining a growing national network dedicated to excellence in the prevention, diagnosis, and treatment of blood clots.
This recognition reflects the outstanding multidisciplinary efforts across IU Health, including teams at both Methodist and University hospitals. Their collaboration has been instrumental in achieving the high standards required for this designation. As IU Health prepares to integrate these hospitals into a single, state-of-the-art facility, this designation will carry forward — underscoring a continued commitment to excellence in VTE care.
‘This designation reflects our team’s tireless efforts to implement timely diagnosis, appropriate treatment, and long-term prevention strategies for patients at risk of blood clots,’ said Paul Haste, MD. ‘We could not be more excited to partner with NBCA to continue this important work improving care for patients throughout the state of Indiana.’
Congratulations to IU Health Methodist Hospital for this well-deserved honor.”
Stay updated on the latest news in the field of hematology with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring